Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Striverdi?

See the DrugPatentWatch profile for Striverdi

What is Striverdi?

Striverdi is the brand name for olodaterol, a long-acting beta2-agonist (LABA) medicine used to treat chronic obstructive pulmonary disease (COPD). It helps relax the airways and makes breathing easier by providing effects that last about a full day [1].

How does Striverdi work?

As a LABA, Striverdi stimulates beta2 receptors in the airways. This relaxes airway smooth muscle and helps improve airflow in people with COPD [1].

How is Striverdi used (and what device is it given with)?

Striverdi is inhaled, and it is used as a maintenance (daily) COPD controller rather than as quick relief for sudden breathing problems. The exact inhaler technique depends on the specific Striverdi inhaler product used in your country [1].

How quickly does it start working, and how long does it last?

Because it is long-acting, Striverdi is meant to provide steady bronchodilation over the day, supporting day-to-day symptom control in COPD [1].

Can Striverdi be used for asthma?

Striverdi is indicated for COPD (not asthma). Using it for asthma would not match the COPD-focused indication and could be unsafe depending on the patient’s condition and local prescribing guidance [1].

What are common side effects people ask about?

Common effects expected from LABA therapy can include tremor, headache, fast heartbeat (palpitations), and muscle cramps. Serious or persistent symptoms should be discussed with a clinician promptly [1].

What happens if someone misses a dose?

If you miss a dose, the usual approach for long-acting inhalers is to use it when you remember unless it’s close to the next scheduled dose. Do not double up without clinician advice. (Exact instructions depend on the product instructions where you live.)

---

Sources

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/



Other Questions About Striverdi :

Striverdi respimat generic when will it be launched?